Ambu A/S Financials

AMBFF Stock  USD 19.90  0.00  0.00%   
You can use fundamental analysis to find out if Ambu A/S is mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to analyze and collect data for thirty-one available fundamental indicators for Ambu AS, which can be compared to its peers. The stock experiences a normal downward fluctuation but is a risky buy. Check odds of Ambu A/S to be traded at $19.7 in 90 days.
  
Understanding current and past Ambu A/S Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Ambu A/S's financial statements are interrelated, with each one affecting the others. For example, an increase in Ambu A/S's assets may result in an increase in income on the income statement.

Ambu A/S Stock Summary

Ambu A/S competes with Rezolute, Tempest Therapeutics, Forte Biosciences, Dyadic International, and DiaMedica Therapeutics. Ambu AS develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. Ambu AS was founded in 1937 and is headquartered in Ballerup, Denmark. AMBU AS is traded on OTC Exchange in the United States.
InstrumentUSA Pink Sheet View All
ExchangePINK Exchange
Business AddressBaltorpbakken 13, Ballerup,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.ambu.com
Phone45 72 25 20 00
CurrencyUSD - US Dollar

Ambu A/S Key Financial Ratios

There are many critical financial ratios that Ambu A/S's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Ambu A/S reports annually and quarterly.

Ambu Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Ambu A/S's current stock value. Our valuation model uses many indicators to compare Ambu A/S value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ambu A/S competition to find correlations between indicators driving Ambu A/S's intrinsic value. More Info.
Ambu AS is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.60  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Ambu AS is roughly  1.67 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ambu A/S's earnings, one of the primary drivers of an investment's value.

Ambu A/S Systematic Risk

Ambu A/S's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Ambu A/S volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Ambu A/S correlated with the market. If Beta is less than 0 Ambu A/S generally moves in the opposite direction as compared to the market. If Ambu A/S Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Ambu A/S is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Ambu A/S is generally in the same direction as the market. If Beta > 1 Ambu A/S moves generally in the same direction as, but more than the movement of the benchmark.

Ambu A/S November 24, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Ambu A/S help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ambu AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ambu AS based on widely used predictive technical indicators. In general, we focus on analyzing Ambu Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ambu A/S's daily price indicators and compare them against related drivers.

Complementary Tools for Ambu Pink Sheet analysis

When running Ambu A/S's price analysis, check to measure Ambu A/S's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ambu A/S is operating at the current time. Most of Ambu A/S's value examination focuses on studying past and present price action to predict the probability of Ambu A/S's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ambu A/S's price. Additionally, you may evaluate how the addition of Ambu A/S to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
CEOs Directory
Screen CEOs from public companies around the world